Post-Operative Kinesio Taping Impact on Pain in Thoracotomy vs Thoracoscopy

NCT05200689 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 310

Last updated 2022-01-21

No results posted yet for this study

Summary

The project is of a comparative nature. It seeks to study pain reduction following two forms of chest surgery and compare results between both procedures. It will use kinesio taping as the studied pain reducer. It will involve 4 study groups, 2 per surgical procedure, and among those 2 main groups, 2 subgroups each where 1 has kinesio taping and the other doesn't.

With this, the project hopes to offer new forms of pain reduction that are more cost effective and are associated with less adverse effects. Furthermore it would decrease pain killer intake which is a contemporary challenge of medicine.

Conditions

  • Post Operative Pain

Interventions

DEVICE

Kinesiotaping (KT)

Kinesio taping will only be applied for a period of 5 days. Initial Kinesio taping will first occur one day after surgery. It will be placed directly on the chest wall on a trigger point. Physiotherapists will be instructed to maintain a standard Tape length (To body size ratio) and tension among all patients of all KT groups. The edges of the tape must be rounded, to prevent premature peeling. The adhesive side of the tape must not be touched after removing its backing, to prevent any decrease in tape adherence. It will be applied using both I and Star applications. Star and I KT application is done directly above the main pain trigger point. This point is found via chest palpitations. The Tape will be replaced every 48 hours by the physiotherapist until the end of therapy. The tape must be placed after stretching the skin.

Sponsors & Collaborators

  • Makassed Hospital

    collaborator OTHER
  • Assiut University

    collaborator OTHER
  • Tanta University

    collaborator OTHER
  • Papworth Hospital NHS Foundation Trust

    collaborator OTHER_GOV
  • European Institute of Oncology

    collaborator OTHER
  • Al-Quds University

    lead OTHER

Principal Investigators

  • Peter R. Bael · Al-Quds University

  • Raya Amro · Al-Quds University

  • Mayar Idkedek · Al-Quds University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-09
Primary Completion
2022-08-01
Completion
2022-09-01

Countries

  • Egypt
  • Italy
  • Palestinian Territories
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05200689 on ClinicalTrials.gov